4.6 Article

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

期刊

LANCET GLOBAL HEALTH
卷 4, 期 11, 页码 E806-E815

出版社

ELSEVIER SCI LTD
DOI: 10.1016/S2214-109X(16)30199-1

关键词

-

资金

  1. Bill & Melinda Gates Foundation (TB Modelling and Analysis Consortium) [OPP1084276]
  2. UK Medical Research Council [MR/J005088/1]
  3. CDC/PEPFAR via the Aurum Institute [U2GPS0008111]
  4. National Science Foundation Graduate Research Fellowship [DGE-114747]
  5. National Institutes of Health NIA Career Development Award [K01 AG037593-01A1]
  6. Stanford's Freeman Spogli Institute for International Studies and Global Underdevelopment Action Fund
  7. Bill & Melinda Gates Foundation
  8. Global Good Fund
  9. National Institutes of Allergy and Infectious Diseases, NIH [AI093856]
  10. National Health and Medical Research Council career development fellowship
  11. Medical Research Council [MR/K010174/1, MR/K010174/1B, MR/J005088/1] Funding Source: researchfish
  12. MRC [MR/J005088/1, MR/K010174/1] Funding Source: UKRI

向作者/读者索取更多资源

Background The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets are feasible in three high-burden countries with contrasting epidemiology and previous programmatic achievements. Methods 11 independently developed mathematical models of tuberculosis transmission projected the epidemiological impact of currently available tuberculosis interventions for prevention, diagnosis, and treatment in China, India, and South Africa. Models were calibrated with data on tuberculosis incidence and mortality in 2012. Representatives from national tuberculosis programmes and the advocacy community provided distinct country-specific intervention scenarios, which included screening for symptoms, active case finding, and preventive therapy. Findings Aggressive scale-up of any single intervention scenario could not achieve the post-2015 End TB Strategy targets in any country. However, the models projected that, in the South Africa national tuberculosis programme scenario, a combination of continuous isoniazid preventive therapy for individuals on antiretroviral therapy, expanded facility-based screening for symptoms of tuberculosis at health centres, and improved tuberculosis care could achieve a 55% reduction in incidence (range 31-62%) and a 72% reduction in mortality (range 64-82%) compared with 2015 levels. For India, and particularly for China, full scale-up of all interventions in tuberculosis-programme performance fell short of the 2025 targets, despite preventing a cumulative 3.4 million cases. The advocacy scenarios illustrated the high impact of detecting and treating latent tuberculosis. Interpretation Major reductions in tuberculosis burden seem possible with current interventions. However, additional interventions, adapted to country-specific tuberculosis epidemiology and health systems, are needed to reach the post-2015 End TB Strategy targets at country level. Copyright (C) The Author(s). Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据